Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Title||The Purpose of This Trial is to Determine if Regorafenib Plus Durvalumab (MEDI4736) is Safe and Effective in Treatment of Chemo Refractory Advanced Biliary Tract Cancers|
|Sponsors||University of Kansas Medical Center|
|Age Groups:||adult | senior|
|University of Kansas Cancer Center - Overland Park||Recruiting||Overland Park||Kansas||66210||United States||Details|
|The University of Kansas Medical Center||Recruiting||Westwood||Kansas||66205||United States||Details|
|University of Kansas Cancer Center - North||Recruiting||Kansas City||Missouri||64154||United States||Details|
|University of Kansas Cancer Center - Lee's Summit||Recruiting||Lee's Summit||Missouri||64064||United States||Details|
|The University of Kansas Medical Center||Recruiting||North Kansas City||Missouri||64116||United States||Details|